Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis

Linschoten, M; Kamphuis, JAM; Van Rhenen, A; Bosman, LP; Cramer, MJ; Doevendans, PA; Teske, AJ; Asselbergs, FW

Linschoten, M (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, NL-3508 GA Utrecht, Netherlands.

LANCET HAEMATOLOGY, 2020; 7 (4): E295